Medical Information Only. Always consult your healthcare provider before enrolling in any clinical trial.
NCT04315077 · ClinicalTrials.gov registry record · NA
The Short Term Effects of Oceanix Supplementation on Recovery
A NA study, sponsored by Applied Science & Performance Institute.
- Completed
- Registry status
- NA
- Development phase
- 22
- Enrollment target
NCT04315077 is a NA study that has completed, run by Applied Science & Performance Institute. The registered enrollment target is 22 participants.
The verdict
NCT04315077, a NA study, has completed, sponsored by Applied Science & Performance Institute.
- COMPLETED
- Registry status
- NA
- Development phase
- 22 participants
- Enrollment target
Study Summary
The purpose of this study will be to examine the effects of Oceanix supplementation on isometric mid-thigh pull force kinetics and salivary immunoglobulin A (indice of immune function) following a one-week intense resistance training protocol. The study will be carried out in a randomized, double-blind, placebo-controlled, parallel manner. Subjects will be stratified into quartiles based on peak force achieved in the isometric mid-thigh pull assessment during screen and prior to baseline testing. Subjects from each quartile will be randomly divided by into treatment and or placebo conditions. Following randomization, subjects will be baseline tested on isometric mid-thigh pull and salivary immunoglobulin A. Following baseline testing, subject will be given their respective supplement conditions and will be instructed to consume one serving (25mg) a day for 21 consecutive days. For days 1 through 14 subjects will be asked to refrain from resistance training. Subjects will undergo a five day intense resistance training protocol will on day 15 to day 19. Subjects will complete follow-up testing in a manner identical to baseline on day 20 and 21 (24- and 48-hours post completion of the training protocol).
Interventions
- OTHER Resistance Training
- DIETARY_SUPPLEMENT Oceanix®
Trial Details
| Field | Value |
|---|---|
| Enrollment Target | 22 participants |
| Start Date | 2019-10-01 |
| Est. Completion | 2019-11-25 |
| Phase | NA |
Interested in This Trial?
Full Details on ClinicalTrials.gov ↗What the Registry Record Tells You About NCT04315077
The ClinicalTrials.gov registry entry for NCT04315077 describes a study currently listed as completed, categorized as NA. The registered enrollment target is 22 participants, a figure that helps gauge the scale of data the investigators plan to collect. The listed sponsor is Applied Science & Performance Institute, which has 20 total studies on file at ClinicalTrials.gov.
The record links to 0 conditions, and to 2 interventions - of which Resistance Training is the first listed.
NCT04315077 reports 0 study locations.
Frequently Asked Questions
What is clinical trial NCT04315077 about?
NCT04315077 is a clinical study titled "The Short Term Effects of Oceanix Supplementation on Recovery". The purpose of this study will be to examine the effects of Oceanix supplementation on isometric mid-thigh pull force kinetics and salivary immunoglobulin A (indice of immune function) following a one-week intense resistance training protocol. The study will be carried out in a randomized, double-bl...
What is the current status of trial NCT04315077?
This trial is currently completed. It is a NA study. The enrollment target is 22 participants. The study started on 2019-10-01. Estimated completion is 2019-11-25.
What interventions are being tested in trial NCT04315077?
The interventions under investigation include: Resistance Training (OTHER), Oceanix® (DIETARY_SUPPLEMENT).
Who is sponsoring clinical trial NCT04315077?
This trial is sponsored by Applied Science & Performance Institute, which has 20 total clinical trials registered on ClinicalTrials.gov.
Learn More About Clinical Trials
Explore more on PlainTrial
Read our methodology - how this data is sourced, computed, and verified.
Related
Every figure on PlainTrial is rendered directly from the ClinicalTrials.gov registry, no number is typed in by an editor. This page mirrors this trial's own ClinicalTrials.gov registry record, live from the dataset. See our editorial standards & corrections policy, the methodology behind these numbers, or report a data error.